Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 10:41 PM
Ignite Modification Date: 2025-12-25 @ 8:12 PM
NCT ID: NCT00075335
Description: None
Frequency Threshold: 0
Time Frame: None
Study: NCT00075335
Study Brief: AMD 3100 (Mozobil Plerixafor) to Mobilize Stem Cells for Donation
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
AMD 3100 (Mozobil Plerixafor ) Volunteers Peripheral blood hematopoietic progenitor cell mobilization with AMD 3100 (Mozobil plerixafor) in healthy volunteers None None 0 8 8 8 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
elevated Monos (expected) NON_SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders None View
elevated WBCs (expected) NON_SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders None View
auditory (R ear) pain NON_SYSTEMATIC_ASSESSMENT Ear and labyrinth disorders None View
Cramps, abdominal NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View
feel need to vomit, no nausea NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View
Headache NON_SYSTEMATIC_ASSESSMENT General disorders None View
Hot feeling NON_SYSTEMATIC_ASSESSMENT General disorders None View
Swelling, leg NON_SYSTEMATIC_ASSESSMENT General disorders None View
Injection site (erythema) NON_SYSTEMATIC_ASSESSMENT Immune system disorders None View
Injection site (induration) NON_SYSTEMATIC_ASSESSMENT Immune system disorders None View
Injection site (pain) NON_SYSTEMATIC_ASSESSMENT Immune system disorders None View
Injection site (pruritus) NON_SYSTEMATIC_ASSESSMENT Immune system disorders None View
muscle pain NON_SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders None View
paresthesia (facial tingling) NON_SYSTEMATIC_ASSESSMENT Nervous system disorders None View
Syncope NON_SYSTEMATIC_ASSESSMENT Nervous system disorders None View
elevated LDH NON_SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders None View
elevated Lymphs (efficacy measure) NON_SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders None View
elevated lymphs (expected) NON_SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders None View
elevated Polys (expected) NON_SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders None View
Sinus tachycardia (rate 103) NON_SYSTEMATIC_ASSESSMENT Cardiac disorders None View